Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for ?1-adrenoceptor binding sites
- 1 December 1987
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 336 (6), 597-601
- https://doi.org/10.1007/bf00165749
Abstract
The mechanism responsible for the antihypertensive effect of urapidil is not yet completely understood. Its vasodilator action has been attributed to an antagonism at vascular α1-adrenoceptors. However, it has been suggested that a central action contributes to the hypotensive effect. Recently, three potent analogues of urapidil have been described which also lower blood pressure by a central mechanism. 5-Hydroxytryptamine (5-HT) receptors of the 5-HT1A subtype have been implicated with the central control of cardiovascular function. In the present study, the affinities of these urapidil derivatives (5-acetyl, 5-formyl- and 5-methylurapidil) for 5-HT receptors were investigated using 3H-8-hydroxy-2-(di-n-propylamino)tetralin (3H-8-OH-DPAT), 125I-iodocyanopindolol (125I-ICYP) and 3H-ketanserin for labelling 5-HT1A, 5-HT1B and 5-HT2 binding sites, respectively. 3H-Prazosin and 3H-clonidine were used as selective α1- and α2-adrenoceptor radioligands, respectively. Urapidil and its analogues produced half-maximum inhibition of 3H-8-OH-DPAT binding at concentrations of 4 × 10−9 mol/l to 4 × 10−7 mol/l with the following order of potency: urapidil < 5-acetyl- < 5-formyl- < 5-methyl-urapidil. Thus, 5-methyl-urapidil is one of the most potent ligands at 5-HT1A recognition sites known to date. The IC50 values of urapidil and its derivatives for 3H-prazosin binding were in the range of 5 × 10−8 mol/l to 8 × 10−7 mol/l (order of potency: urapidil < 5-formyl- < 5-acetyl- ≤ 5-methyl-urapidil). The affinity of these analogues for 5-HT1B, 5-HT2 and α2-adrenergic recognition sites was distinctly lower. Urapidil and its congeners clearly discriminate between 5-HT- and between α-receptor subtypes. It is postulated that the high affinity for 5-HT1A receptors as well as for α1-adrenoceptors is relevant to the hypotensive properties of these compounds.Keywords
This publication has 25 references indexed in Scilit:
- Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological AnalysisJournal of Cardiovascular Pharmacology, 1987
- The central site of the sympatho-inhibitory action of 5-hydroxytryptamine in the catNeuropharmacology, 1987
- Hypotensive Effect of Urapidil: CNS Site and Relative ContributionJournal of Cardiovascular Pharmacology, 1987
- INFLUENCE OF URAPIDIL ON α‐ AND β‐ADRENORECEPTORS IN PITHED RATSJournal of Autonomic Pharmacology, 1985
- Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]KetanserinEuropean Journal of Pharmacology, 1985
- Characterization of the 5-HTIB recognition site in rat brain: Binding studies with (−)[125I]IodocyanopindololEuropean Journal of Pharmacology, 1985
- [3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat BrainJournal of Neurochemistry, 1985
- A practical computer-based approach to the analysis of radioligand binding experimentsComputer Programs in Biomedicine, 1983
- Review of the role of the central serotonergic neuronal system in blood pressure regulation.Hypertension, 1980
- Investigations on the mode of action of a new antihypertensive drug, urapidil, in the isolated rat vas deferensEuropean Journal of Pharmacology, 1979